BioSpace News Archive

Business

AroCell Signs Letter of Intent With Korean-Based Company, Green Cross Cell Corporation

he companies have agreed to enter into a collaboration for the clinical development of TK 210 ELISA.

November 22, 2017
·
2 min read
Business

AroCell AB: Reporting Period 1 July - 30 September 2017

Sales for the period were 0 (46). Expenses were 3,678 (2,590).

November 22, 2017
·
8 min read
Genetown

Analogic Corporation to Webcast Annual Stockholders’ Meeting - Nov. 20, 2017

Bernard Bailey, chairman of the board for Analogic, will host the meeting.

November 22, 2017
·
1 min read
Prima Secures European Patent Grant for Lead Product IMP321 in Cancer

This European patent was filed as a divisional application and follows the grant of the European parent patent, which was issued in August 2013.

November 22, 2017
·
1 min read
Business

SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre for Proteomics and Mass Spectrometry Across Asia Pacific

PPC and SCIEX have established a strong partnership since the inauguration of PPC at NUS Faculty of Science in 2000.

November 22, 2017
·
5 min read
Policy

Portola Pharmaceuticals Provides Update on Bevyxxa (betrixaban) Commercial Launch

The new action date is January 30, 2018.

November 22, 2017
·
6 min read
Pharm Country

Quadrant Biosciences Release: Salivary microRNA May Predict Duration and Nature of Concussion Symptoms Among Children

Small molecules in saliva may hold the key to predicting the type and duration of concussion symptoms, according to a study just published in the JAMA.

November 22, 2017
·
4 min read
Drug Development

GENFIT: Positive Outcome From the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase III Clinical Trial With elafibranor

NASH being considered as a chronic condition, safety is crucial for any drug candidate aiming to address the unmet clinical needs related to this pathology.

November 22, 2017
·
4 min read
Drug Development

First Patients Enter TARGET Study, Recently Initiated by Cerenis Therapeutics to Evaluate HDL Nanoparticles in Patients with Esophageal Cancer

TARGET is the first ever performed clinical study testing the potential of labelled HDL to visualize tumors in cancer patients.

November 22, 2017
·
8 min read
Alzheimer’s Research UK Release: Autumn Budget Misses Mark for Dementia

Alzheimer’s Research UK is calling on the government to make continued commitments that support world-class research to address dementia.

November 22, 2017
·
1 min read